FAM133A
Protein FAM133A
Also known as: CT115, F133A_HUMAN, FLJ37659, RP1-32F7.2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N9E0
- Gene
- FAM133A
- Ensembl
- ENSG00000179083
- Chromosome
- X
- Canonical length
- 248 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
No narrative summary is available for FAM133A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>Q8N9E0|FAM133A
1 MGKRDNRVAY MNPIAMARWR GPTQSVGPTI QDYLNRPRPT WEEVKKQLEN KKTGSKALAE
61 FEEKMNENWK KELEKSREKL LSGNESSSKK RERKKKRKKK SCRSSSSSSS SDSSSSSSDS
121 EDEEKKQGKR RKKKKNRSYK SSQSSTHESE SESKESVKKK KKSKDETEKE KDVRSLSKKR
181 KKSYPDDKPL SSESSSESDY EEDVQAKKKR RCEEREQAKE KVKKKKKKQH KKHSKKKKKK
241 SGSSHKSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAM133A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 7.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 7.3 nTPM
- cerebral cortex: 2.9 nTPM
- basal ganglia: 1.5 nTPM
- hypothalamus: 1.4 nTPM
- retina: 1.3 nTPM
- adrenal gland: 1.2 nTPM
Single-cell type
- sertoli cells: 386 nCPM
- differentiating spermatogonia: 44 nCPM
- late spermatids: 42 nCPM
- undifferentiated spermatogonia: 38 nCPM
- somatotrophs: 36 nCPM
- adrenal medulla cells: 32 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 6.9 nTPM
- pons: 6.1 nTPM
- midbrain: 5.6 nTPM
- basal ganglia: 4.6 nTPM
- cerebral cortex: 4.1 nTPM
- thalamus: 3.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0.4
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
InteractionsUniProt · HPA
Protein binding partners of FAM133A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAM133A as an antibody target. Whether an autoantibody or antibody against FAM133A could matter depends on whether native FAM133A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAM133A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAM133A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...